Chronic myelomonocytic leukemia in a 72-year-old male from Nepal: A case report
Open Access
- 1 February 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (2) , 257-260
Abstract
Introduction: Chronic myelomonocytic leukemia (CMML) is a rare disease of clonal hematopoietic stem cells with an inherent risk of leukemic transformation, seen in an elderly male. Case Presentation: Herein, the authors report a case of CMML in a 72-year-old male who presented with fever and abdominal pain for 2 days with a history of easy fatigability. Examination revealed pallor and palpable supraclavicular nodes. Investigations showed leukocytosis with a monocyte count of 22% of white blood cell count, 17% blast cells in bone marrow aspiration, increased blast/promonocytes, and positive markers in immunophenotyping. The patient is planned for injection of azacitidine, 7 days cycle for a total of six cycles. Clinical Discussion: CMML is classified as overlapping myelodysplastic/myeloproliferative neoplasms. It can be diagnosed based on a peripheral blood smear, bone marrow aspiration and biopsy, chromosomal analysis, and genetic tests. The commonly used treatment options are hypomethylating agents like azacitidine and decitabine, allogeneic hematopoietic stem cell transplant, and cytoreductive agents like hydroxyurea. Conclusion: Despite various treatment options, the treatment is still unsatisfactory, demanding standard management strategies.Keywords
This publication has 10 references indexed in Scilit:
- How I diagnose and treat chronic myelomonocytic leukemiaHaematologica, 2022
- Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2022
- Diagnosis and treatment of chronic myelomonocytic leukemiaBlood Research, 2021
- The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) GuidelinesInternational Journal of Surgery, 2020
- Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and managementAmerican Journal of Hematology, 2018
- CMML: Clinical and molecular aspectsInternational Journal of Hematology, 2017
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the NetherlandsLeukemia Research, 2015
- Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeBlood Cancer Journal, 2015
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programsBlood, 2008